Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy

Clinical trial NCT00772694 · UNKNOWN

Trial details

NCT number: NCT00772694
Sponsor: Fondation Wygrajmy Zdrowie
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Testicular Cancer

Start date: 2008-09-01
Primary completion: 2011-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.